Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES

Detalles Bibliográficos
Autores principales: Ferraccioli, Gianfranco, Tolusso, Barbara, Fedele, Anna Laura, Gremese, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823584/
https://www.ncbi.nlm.nih.gov/pubmed/27099779
http://dx.doi.org/10.1136/rmdopen-2016-000263
_version_ 1782425940778811392
author Ferraccioli, Gianfranco
Tolusso, Barbara
Fedele, Anna Laura
Gremese, Elisa
author_facet Ferraccioli, Gianfranco
Tolusso, Barbara
Fedele, Anna Laura
Gremese, Elisa
author_sort Ferraccioli, Gianfranco
collection PubMed
description
format Online
Article
Text
id pubmed-4823584
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48235842016-04-20 Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES Ferraccioli, Gianfranco Tolusso, Barbara Fedele, Anna Laura Gremese, Elisa RMD Open Editorial BMJ Publishing Group 2016-03-25 /pmc/articles/PMC4823584/ /pubmed/27099779 http://dx.doi.org/10.1136/rmdopen-2016-000263 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Editorial
Ferraccioli, Gianfranco
Tolusso, Barbara
Fedele, Anna Laura
Gremese, Elisa
Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES
title Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES
title_full Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES
title_fullStr Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES
title_full_unstemmed Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES
title_short Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES
title_sort do we need to apply a t2t strategy even in acpa-negative early rheumatoid arthritis? yes
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823584/
https://www.ncbi.nlm.nih.gov/pubmed/27099779
http://dx.doi.org/10.1136/rmdopen-2016-000263
work_keys_str_mv AT ferraccioligianfranco doweneedtoapplyat2tstrategyeveninacpanegativeearlyrheumatoidarthritisyes
AT tolussobarbara doweneedtoapplyat2tstrategyeveninacpanegativeearlyrheumatoidarthritisyes
AT fedeleannalaura doweneedtoapplyat2tstrategyeveninacpanegativeearlyrheumatoidarthritisyes
AT gremeseelisa doweneedtoapplyat2tstrategyeveninacpanegativeearlyrheumatoidarthritisyes

Ejemplares similares